Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Sales | 3,344 | 2,275 | 1,413 | 1,144 | 551 |
| Cost of Goods | 2,306 | 1,465 | 1,025 | 831 | N/A |
| Gross Profit | 1,039 | 810 | 389 | 313 | 551 |
| Operating Expenses | 3,281 | 7,665 | 11,388 | 12,693 | 6,557 |
| Operating Income | -1,936 | -6,390 | -10,974 | -11,549 | -6,007 |
| Interest Expense | 1,532 | 252 | 292 | 275 | 284 |
| Other Income | -4,589 | 41 | 356 | 664 | -593 |
| Pre-tax Income | -8,057 | -6,602 | -10,910 | -11,161 | -6,883 |
| Income Tax | N/A | -3 | -3 | -1 | 1 |
| Net Income Continuous | -8,057 | -6,599 | -10,914 | -11,162 | -6,884 |
| Net Income Discontinuous | N/A | N/A | -2,980 | -642 | N/A |
| Net Income | $-8,057 | $-6,605 | $-13,893 | $-11,804 | $-6,884 |
| EPS Basic Total Ops | -0.11 | -0.27 | -0.73 | -0.64 | -0.49 |
| EPS Basic Continuous Ops | -0.11 | -0.21 | -0.50 | -0.56 | -0.37 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.14 | -0.03 | N/A |
| EPS Diluted Total Ops | -0.11 | -0.27 | -0.73 | -0.64 | -0.49 |
| EPS Diluted Continuous Ops | -0.11 | -0.21 | -0.50 | -0.56 | -0.37 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.14 | -0.03 | N/A |
| EBITDA(a) | $-1,428 | $-5,890 | $-10,561 | $-11,141 | $-5,520 |